Notice of Clarification of Institutional Eligibility for PAR-19-218 "Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)

Notice Number: NOT-GM-19-038

Key Dates
Release Date: April 12, 2019

Related Announcements
PAR-19-218

Issued by
National Institute of General Medical Sciences (NIGMS)

Purpose

The purpose of this Notice is to revise language regarding institutional eligibility in PAR-19-218 "Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)” to clarify that research active institutions are defined as those withNIH Research Project Grant funding averaging less than $7.5 million total costs (direct and F&A/indirect) per year over the last three fiscal years.

The following is detailed information about the modifications to the FOA.

Part I Overview Information

Funding Opportunity Purpose

Current Language

The goal of the Undergraduate Research Training Initiative for Student Enhancement (U-RISE) program is to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete biomedical, research-focused higher degree programs (e.g., Ph.D. or M.D./Ph.D.). This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements to prepare trainees for the completion of research-focused higher degree programs in biomedical fields. This program is limited to applications from training programs at baccalaureate degree-granting research-active institutions (i.e., those with an average of NIH Research Project Grant funding less than $7.5 million total costs over the last 3 fiscal years)).

Revised Language

The goal of the Undergraduate Research Training Initiative for Student Enhancement (U-RISE) program is to develop a diverse pool of undergraduates who complete their baccalaureate degree, and transition into and complete biomedical, research-focused higher degree programs (e.g., Ph.D. or M.D./Ph.D.). This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring, and career development elements to prepare trainees for the completion of research-focused higher degree programs in biomedical fields. This program is limited to applications from training programs at baccalaureate degree-granting research-active institutions (i.e., those with NIH Research Project Grant funding averaging less than $7.5 million total costs (direct and F&A/indirect) per year over the last three fiscal years).

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Purpose and Background Information

Current Language

NIGMS strives to ensure that future generations of researchers will be drawn from the entire pool of talented individuals, bringing different aptitudes, perspectives, interests, and experiences to address complex scientific problems. NIGMS seeks to enhance the diversity of the biomedical research workforce by supporting individuals from a variety of backgrounds at multiple training and career stages in a variety of institutions and educational settings across the country. Accordingly, NIGMS developed separate institutional eligibility tracks for review and funding of its undergraduate and graduate diversity enhancing programs based on NIH research project grant (RPG) funding levels. The two tracks include research-intensive, i.e., those with an average of NIH RPG funding greater than or equal to $7.5 million total costs over the past 3 fiscal years, and research-active, i.e., those with an average of RPG funding less than $7.5 million total costs over the past 3 fiscal years (RPG data are available through NIH RePORTER). To prevent the duplication of diversity enhancing NIGMS programs, each institution will be eligible for one diversity enhancing undergraduate program (either Maximizing Access to Research Careers, MARC, or U-RISE) regardless of the activity code (R25 or T34), and one diversity enhancing graduate program (either the Initiative to Maximize Student Development, IMSD , or Graduate Research Training Initiative for Student Enhancement, G-RISE) regardless of the activity code (R25 or T32). Institutions with MARC, U-RISE, IMSD or G-RISE are eligible to participate in the Bridges to the Baccalaureate and/or Bridges to the Doctorate programs.

Revised Language

NIGMS strives to ensure that future generations of researchers will be drawn from the entire pool of talented individuals, bringing different aptitudes, perspectives, interests, and experiences to address complex scientific problems. NIGMS seeks to enhance the diversity of the biomedical research workforce by supporting individuals from a variety of backgrounds at multiple training and career stages in a variety of institutions and educational settings across the country. Accordingly, NIGMS developed separate institutional eligibility tracks for review and funding of its undergraduate and graduate diversity enhancing programs based on NIH research project grant (RPG) funding levels. The two tracks include research-intensive, i.e., those with NIH RPG funding averaging greater than or equal to $7.5 million total costs (direct and F&A/indirect) per year over the past three fiscal years, and research-active, i.e., those with RPG funding averaging less than $7.5 million total costs (direct and F&A/indirect) per year over the past three fiscal years (RPG data are available through NIH RePORTER). To prevent the duplication of diversity enhancing NIGMS programs, each institution will be eligible for one diversity enhancing undergraduate program (either Maximizing Access to Research Careers, MARC, or U-RISE) regardless of the activity code (R25 or T34), and one diversity enhancing graduate program (either the Initiative to Maximize Student Development, IMSD , or Graduate Research Training Initiative for Student Enhancement, G-RISE) regardless of the activity code (R25 or T32). Institutions with MARC, U-RISE, IMSD or G-RISE are eligible to participate in the Bridges to the Baccalaureate and/or Bridges to the Doctorate programs.

Part 2. Full Text of Announcement

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Current Language

For diversity enhancing programs, NIGMS recognizes separate institutional eligibility tracks:research-intensive, i.e., those with an average of NIH research project grant (RPG) funding greater than or equal to $7.5 million total costs over the past 3 fiscal years; and research-active, i.e., those with an average of RPG funding less than $7.5 million total costs over the past 3 fiscal years (RPG data are available through NIH RePORT). For example, FY 2016, FY 2017 and FY 2018 for applications submitted in May 2019.

Revised Language

For diversity enhancing programs, NIGMS recognizes separate institutional eligibility tracks: research-intensive, i.e., those with NIH research project grant (RPG) funding averaging greater than or equal to $7.5 million total costs (direct and F&A/indirect) per year over the past three fiscal years; and research-active, i.e., those with RPG funding averaging less than $7.5 million total costs (direct and F&A/indirect) per year over the past three fiscal years (RPG data are available through NIH RePORT). For example, FY 2016, FY 2017 and FY 2018 for applications submitted in May 2019.

Applicants are encouraged to consult NIGMS staff to discuss eligibility prior to submission.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Anissa J. Brown, Ph.D.
National Institute of General Medical Sciences
Email: [email protected]

Luis A. Cubano, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]